BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29635274)

  • 1. Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study.
    Weberpals J; Jansen L; Müller OJ; Brenner H
    Eur Heart J; 2018 Nov; 39(43):3896-3903. PubMed ID: 29635274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
    Boekel NB; Schaapveld M; Gietema JA; Russell NS; Poortmans P; Theuws JC; Schinagl DA; Rietveld DH; Versteegh MI; Visser O; Rutgers EJ; Aleman BM; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1061-72. PubMed ID: 27026313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.
    Hooning MJ; Aleman BM; van Rosmalen AJ; Kuenen MA; Klijn JG; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1081-91. PubMed ID: 16446057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
    Darby SC; McGale P; Taylor CW; Peto R
    Lancet Oncol; 2005 Aug; 6(8):557-65. PubMed ID: 16054566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause-specific mortality among patients with different molecular subtypes of T1-2N0M0 breast cancer: A population-based study.
    Wang D; Yi L; Zhang L; Wang Z
    Medicine (Baltimore); 2021 Oct; 100(43):e27605. PubMed ID: 34713838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
    Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
    JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of risk factors for mortality in patients with cardiovascular disease and a history of treatment for malignancy.
    Rydzek J; Gąsior ZT; Dąbek J; Wojnar J; Skrzypek M
    Kardiol Pol; 2015; 73(9):730-9. PubMed ID: 26390319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study.
    Roychoudhuri R; Robinson D; Putcha V; Cuzick J; Darby S; Møller H
    BMC Cancer; 2007 Jan; 7():9. PubMed ID: 17224064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in heart disease mortality among breast cancer survivors in the US, 1975-2017.
    Vo JB; Ramin C; Barac A; Berrington de Gonzalez A; Veiga L
    Breast Cancer Res Treat; 2022 Apr; 192(3):611-622. PubMed ID: 35107712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Cardiac Disease- and Cancer-Associated Mortalities in Patients With Non-Metastatic Stomach Adenocarcinoma Receiving Resection and Chemotherapy: A Large Competing-Risk Population-Based Cohort Study.
    Huang L; Shi Y; Zhao YJ; Wang L; Hu WG; Zhu ZG; Zhang J
    World J Oncol; 2022 Apr; 13(2):69-83. PubMed ID: 35571338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study).
    Merzenich H; Bartkowiak D; Schmidberger H; Schmidt M; Schwentner L; Wiegel T; Woeckel A; Wollschläger D; Blettner M
    Breast Cancer Res Treat; 2017 Jan; 161(1):143-152. PubMed ID: 27804053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
    Cadoo KA; Morris PG; Cowell EP; Patil S; Hudis CA; McArthur HL
    Clin Breast Cancer; 2016 Dec; 16(6):487-493. PubMed ID: 27622751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cardiac death after adjuvant radiotherapy for breast cancer.
    Giordano SH; Kuo YF; Freeman JL; Buchholz TA; Hortobagyi GN; Goodwin JS
    J Natl Cancer Inst; 2005 Mar; 97(6):419-24. PubMed ID: 15770005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-related heart disease after breast cancer radiation therapy in Korean women.
    Chang JS; Ko BK; Bae JW; Yu JH; Park MH; Jung Y; Jeon YW; Kim KH; Shin J; Suh CO; Kim YB;
    Breast Cancer Res Treat; 2017 Nov; 166(1):249-257. PubMed ID: 28717853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.
    Lancellotti P; Anker SD; Donal E; Edvardsen T; Popescu BA; Farmakis D; Filippatos G; Habib G; Maggioni AP; Jerusalem G; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2015 May; 16(5):466-70. PubMed ID: 25744342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.